New diabetes treatment aids weight loss

An international clinical trial revealed that the oral medication "Eliquisolibreon" demonstrates significant effectiveness in treating type 2 diabetes. It resulted in weight loss of up to 5% of body weight and improved blood sugar levels after 26 weeks. The drug, belonging to the class of GLP-1 receptor agonists, enhances insulin secretion and slows gastric emptying. It now offers a competitive advantage as it is taken orally instead of by injection.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل